申请人:Eli Lilly and Company
公开号:US05576323A1
公开(公告)日:1996-11-19
The present invention provides novel compounds that affect excitatory amino acid receptors and are useful in the treatment of neurological disorders. This invention also provides synthetic methods for the preparation of the novel compounds.
本发明提供了影响兴奋性氨基酸受体并在治疗神经系统疾病中有用的新化合物。该发明还提供了制备这些新化合物的合成方法。